Development of a RNA-Seq Based Prognostic Signature for Lung Cancer

October 7, 2016 Leave a comment 4,473 Views

Precision therapy for lung cancer will require comprehensive genomic testing to identify actionable targets as well as ascertain disease prognosis. RNA-seq is a robust platform that meets these requirements, but microarray-derived prognostic signatures are not optimal for RNA-seq data. Thus, ...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: Prognostic Signature

Development of a RNA-Seq Based Prognostic Signature for Lung Cancer

A LAMP sequencing approach for high-throughput co-detection of SARS-CoV-2 and influenza virus in human saliva

The modulatory role of ions in stem cell transcriptome dynamics by regulating lineage-specific gene expression patterns

Single cell RNA sequencing uncovers new mechanisms of heart disease

ICARUS – an interactive web server for single cell RNA-seq analysis

IMGG – integrating multiple single-cell datasets through connected graphs and generative adversarial networks

Methylation of tRNA-derived fragments regulates gene-silencing activity in bladder cancer

Upcoming Webinar – Cancer Cell Metastases: Understanding the Process Using Insights from Single Cell Sequencing